文献速递前列腺癌

根治性前列腺切除加盆腔淋巴结清扫术中腹膜开窗可显著减少淋巴囊肿

Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection.
PubMed 文献 · BJU Int · 2021-06-09

该研究纳入1513例开放耻骨后根治性前列腺切除(ORP)加盆腔淋巴结清扫(PLND)患者,其中307例(20.3%)接受腹膜开窗。腹膜开窗组淋巴囊肿(LC)发生率6.8%,非开窗组13.9%(P=0.001);需干预的LC在开窗组占2.9%,非开窗组5.0%(P<0.001)。多变量分析显示腹膜开窗与LC风险降低相关(OR 0.33,95%CI 0.2-0.5;P<0.001),倾向性评分匹配后结果一致(OR 0.38,95%CI 0.21-0.68;P=0.001),需治疗人数为14。

要点

  • 腹膜开窗可降低ORP+PLND后淋巴囊肿发生率(6.8% vs 13.9%)。
  • 腹膜开窗减少需干预的淋巴囊肿(2.9% vs 5.0%)。
  • 多变量分析示腹膜开窗降低LC风险(OR 0.33),未见腹部并发症。

核心结论

  • 腹膜开窗可能降低开放耻骨后根治性前列腺切除加(扩大)盆腔淋巴结清扫术后症状性淋巴囊肿的发生率。
  • 因此,腹膜开窗应作为手术策略的一部分。

研究设计与样本

  • 其中307例(20.3%)接受腹膜开窗,1206例(79.7%)未接受。
  • 采用单变量和多变量逻辑回归分析及倾向性评分匹配。

主要发现

  • 中位年龄65(IQR 60-70)岁,中位清扫淋巴结16(IQR 10-22)枚,开窗组22枚 vs 非开窗组14枚(P<0.001)。
  • 总体189例(12.5%)诊断LC,开窗组21例(6.8%) vs 非开窗组168例(13.9%)(P=0.001)。
  • 70例(4.7%)LC需进一步干预(Clavien-Dindo IIIa/b),开窗组2.9% vs 非开窗组5.0%(P<0.001)。
  • 无Clavien-Dindo IV或V级并发症,尤其未观察到与腹膜开窗相关的腹部并发症。
  • 多变量分析:腹膜开窗与LC风险降低相关(OR 0.33,95%CI 0.2-0.5;P<0.001);倾向性评分匹配后OR 0.38(95%CI 0.21-0.68;P=0.001);需治疗人数为14。

临床怎么用

  • 在开放耻骨后根治性前列腺切除加盆腔淋巴结清扫术中可考虑实施腹膜开窗以降低症状性淋巴囊肿风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To reduce the risk of symptomatic lymphocele (SLC), we present a technique using peritoneal fenestration that allows lymphatic fluid to drain into the abdomen, as SLC formation after open retropubic radical prostatectomy (ORP) with pelvic lymph node dissection (PLND) is a common adverse event. PATIENTS AND METHODS: We identified 1513 patients who underwent ORP with PLND between July 2018 and November 2019. Of those, 307 patients (20.3%) received peritoneal fenestration and 1206 (79.7%) no fenestration. The rate of LCs and the necessity for intervention were analysed by uni- and multivariable logistic regression (MLR) models. A propensity score matching was performed, as well. RESULTS: The median (interquartile range [IQR]) age was 65 (60-70) years. A median (IQR) of 16 (10-22) lymph nodes were dissected, 22 vs 14 lymph nodes in the fenestration vs non-fenestration group (P < 0.001). Overall, 189 patients (12.5%) were diagnosed with a LC after ORP, while 21 patients (6.8%) in the fenestration and 168 (13.9%) in the non-fenestration group had LCs (P = 0.001). In 70 patients (4.7%), LCs required further intervention, categorised as Clavien-Dindo Grade IIIa/b, with a smaller proportion in the fenestration group (2.9% vs 5.0% in the non-fenestration group, P < 0.001). There were no Clavien-Dindo Grade IV or V complications, in particular no abdominal complications in association with peritoneal fenestration observed. In MLR, peritoneal fenestration was associated with a reduced risk of LCs (odds ratio [OR] 0.33, 95% confidence interval [CI] 0.2-0.5; P < 0.001). The risk reduction was also shown after propensity score matching (OR 0.38, 95% CI 0.21-0.68; P = 0.001). The number needed to treat was 14. CONCLUSIONS: Peritoneal fenestration may decrease the rate of SLC after ORP with (extended) PLND. Therefore, it should be part of the operative strategy.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Pose RM, Knipper S, Würnschimmel C, et al. Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection. BJU Int. 2021. PMID: 34036733. doi:10.1111/bju.15497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。